Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Haslam, Boyd Announce State Infrastructure Investment Surrounding St. Jude Children's Research Hospital In Shelby County

Governor Bill Haslam and Economic and Community Development Commissioner Randy Boyd on Thursday announced that the state of Tennessee, along with the city of Memphis, will invest in public infrastructure surrounding St. Jude Children’s Research Hospital in Memphis.   The state will invest $12 million in FastTrack funding to improve the public infrastructure surrounding ... (click for more)

Senate Passes 21st Century Cures Bill To Help Find Cures For Cancer And Alzheimer’s, And To Fight Opioid Crisis

Senate health committee Chairman Lamar Alexander on Wednesday said “the most important bill of the year is headed towards the President’s desk,” after the United States Senate passed the 21 st  Century Cures Act by a vote of 94 to 5. “For the second consecutive year, the senate is sending the President another Christmas miracle for his signature. Last year, it was the ... (click for more)

City Administrator Lurone Jennings Suspended For Misallocation Of Funds

Rev. Lurone Jennings, administrator of City Youth and Family Development, has been suspended for one week for misallocation of funds. He also is to be issued a letter of reprimand and will undergo ethics training. The action came after a critical audit report from City Auditor Stan Sewell. It says Mr. Jennings transferred $18,500 of funds to a program, Journey Educational ... (click for more)

New Walker County Commissioner Whitfield To Move Public Meetings To Evenings And To Larger Venue; Will Also Be Listening Sessions

Walker County Sole Commissioner-Elect Shannon Whitfield said there will be a new arrangement for holding of public commissioner sessions when he takes place at the start of January. Current Commissioner Bebe Heiskell has held Thursday meetings at 3:30 p.m. from time to time in a conference room at her office near the Walker County Courthouse in LaFayette. Mr. Whitfield said those ... (click for more)

Roy Couldn't Possibly Be More Wrong - And Response (4)

Spreading false information isn't only harmful, as we've been made aware recently. The spread of false information can be outright dangerous.   Calling himself a Christian and all, Roy truly disappoints on so many levels with his recently opinion piece about black students attending predominately white schools being the cause of so much problems and grief at those schools. ... (click for more)

Roy Exum: Our Senseless Divide

If I could change one thing about the schools in Chattanooga, my wish would be that everybody could become good friends. I’m talking about the private schools versus the public schools. The rancor is so bad we hardly ever play in sports anymore and what the loathsome TSSAA has done in recent years to the out-numbered private schools is sinful. My dream would be that there would ... (click for more)